The total coronary stent market comprises bare-metal stents, drug-eluting stents, covered stents, and bifurcated stents. Stents can be defined as small mesh tubes inserted into an artery to prevent it from collapsing and keep it open after an angioplasty surgery (percutaneous coronary intervention, or PCI). Following multiple clinical studies that presented evidence of over-stenting in

Market trends for both the global Ventricular Assist Device (VAD) and Intra-aortic Balloon Pump (IABP) markets indicate growth over the forecast period and into 2027. Overall, the global VAD and IABP markets had a combined valuation of approximately $2 billion in 2020. These markets expect to reach a combined value of about $3.2 billion by

Overview Technology, especially when it comes to medical devices, is consistently advancing. As a result, it can be challenging to stay on top of the new procedures, devices, and advancements. If you have ever wanted to learn more about mechanical heart valves, the current and projected growth within this market, and how long they last,

Receive a free Interventional Cardiology Devices Market Report Suite for U.S.  synopsis and brochure iData Research, a leading international market research and consulting firm, has published results from their latest cardiovascular research revealing that there are over 2 million stents implanted per year in the United States. Approximately 1.2 Million of these can be attributed

  Intravascular ultrasound (IVUS) is an imaging technique that can be used as an alternative in peripheral procedures. IVUS provides the physician with a cross-sectional image of the vessel. Specifically, the technique is used in endovascular aneurysm repair (EVAR), thoracic endovascular aneurysm repair (TEVAR), carotid, subclavian, mesenteric, renal, iliac, superficial femoral artery (SFA), popliteal, inferior

Over the past few years, the peripheral vascular device market has seen substantial growth. Driven by forward-pressing research, increased awareness about treatment options, and an aging population in the United States, the total number of procedures performed and, therefore, the total number of devices used, has seen a strong and steady increase. One main disease

Keeping up with the market is hard enough without a looming global pandemic swinging it out of control. Although it is difficult to stay on top of recent trends, it is essential if you want to stay ahead of the market and your competition. Continually tracking trends, identifying who is doing well and why, along

Boston Scientific has announced they entered a definitive agreement to acquire Preventice Solutions Inc., a privately-held company that offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors to cardiac event monitors and mobile cardiac telemetry. The transaction will include an upfront cash payment of $925 million, and up

According to a new cardiac surgery market study by iData Research, the number of cardiac surgeries exceeds 900,000 procedures each year in the United States. The US Cardiac surgery market is growing rapidly driven by the growth of many underlying procedures. The number of cardiac surgery procedures commonly includes: • Coronary Artery Bypass Grafting (CABG)•

According to a new atherectomy market study by iData Research, over 190,000 atherectomy procedures are performed each year in the United States. Atherectomy is a procedure that consists of removing atherosclerotic plaque from diseased arteries and can be performed either on coronary or peripheral arteries. Atherectomy devices are used as the treatment of choice, as

Based on the latest market analysis by iData Research, the European Transcatheter Aortic Valve Replacement (also known as TAVR/TAVI) market was valued at €836.2 million in 2020, which is a 29% decline from 2019 due to COVID19. TAVR is a minimally invasive procedure to replace the diseased aortic valve in patients with severe aortic stenosis. 

Medtronic has released its first-ever app-connected pacemaker called Azure. A pacemaker is an implantable device designed to regulate the electrical impulses of the heart. They are used to correct uneven heartbeats. Millions of patients have pacemaker implants to treat arrhythmia or heart failure. However, many patients do not understand how these devices function. This smartphone-connected

According to the latest Cardiac Surgery market study by iData Research, over 182,000 heart valve replacements are performed every year in the United States. Heart valve replacements are one of the most common procedures performed in cardiac surgery market, and they make up nearly a quarter of the total procedure volume. Heart valve replacement procedures

As we progress through the global pandemic and drive closer to having a vaccine available, companies are now preparing supplies such as needles and syringes. We have compiled the top three companies to watch as distributors for needles and syringes in the United States. Becton Dickinson  Cardinal Health Novo Nordisk Becton Dickinson Becton Dickinson produces

Register to receive a free TAVR Market Report Suite for the US 2020-2026 synopsis Based on the latest market analysis by iData Research, the Transcatheter Aortic Valve Replacement (TAVR) market was valued at $2,424 million in 2020, which is a 13% decline from 2019 due to COVID19. TAVR is a minimally invasive procedure to replace

Based on the latest market study by iData Research, the US infusion pump market was valued at almost $1,176 million in 2019. However, due to COVID, the market size is expected to shrink by an astonishing 51% and reach a valuation of $572 million in 2020, before rebounding in 2021. The infusion pump market is

According to the latest interventional cardiology procedural analysis by iData Research, over 965,000 angioplasties are performed each year in the United States. An angioplasty, also known as percutaneous coronary intervention (PCI), is a procedure that involves stent placement to open blocked or narrowing arteries.   Interventional cardiology is primarily applied to the treatment of coronary

Teleflex has announced its receival of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indications for the use of the Arrow® EZ-IO® Intraosseous Vascular Access System. This device is used to provide procedural guidance within the establishment of intraosseous vascular access, especially when intravenous access is difficult to obtain in

Interventional cardiology is a minimally-invasive technique that uses catheters to treat coronary arterial disease, which is one of the leading causes of death in the United States. These procedures allow the heart to continue functioning at its best moving almost 3,000 gallons of blood every day. Based on the European Heart Journal, cardiovascular disease (CVD)

The FDA Breakthrough Devices Program enables manufacturers to streamline the market clearance/approval process for specific medical devices. Medtronic received the breakthrough device designation for its investigational Intrepid™ transcatheter tricuspid valve replacement (TTVR) system. The FDA has also approved an early feasibility study for the device. The new TTVR system will help treat tricuspid valve regurgitation,

Currently, the demand for healthcare workers and facilities is extraordinarily high in areas heavily affected by COVID-19. The demand for patient monitoring devices is also high. One of the biggest challenges in reducing the spread of the virus is contact tracing, which is made difficult through a high demand for health personnel, and because of

Philips has announced the launch of two portable biomedical products, after obtaining FDA approval for them: the Tempus ALS and Tempus Pro. Both of the devices are designed for use with Philips’ Intellispace Corsium software. This web-based platform is used to record and upload data real-time, and it can be used for communication. This adds

Researchers at Purdue University have been developing a wearable cardiac monitor that functions by harvesting the energy of the human body. The device uses TENG’s, triboelectric nanogenerators, with polyvinyl alcohol-based contact layers, to monitor cardiac health. If further research shows this technology is viable, this could be a major step forward for all patient monitoring

The FDA has granted Emergency Use Authorization to Abiomed for their left-sided Impella heart pumps. These pumps are used to support patients during heart failure and provide left ventricular unloading. The long-term effects of COVID-19 are not yet well-understood. Initially, the most focus was placed on respiratory issues and lung damage, which were the most

According to iData’s latest Interventional Cardiology market report, Boston Scientific is the leading competitor in this market. Now, they have produced another innovative interventional cardiology device. The FDA has recently approved Boston Scientific’s stroke prevention device, the Watchman FLX, making it available for sale in the US. This device follows the original edition of the

Medtronic has received a CE mark for its Micra AV Pacemaker, the world’s smallest pacemaker with atrioventricular (AV) synchrony. This device is used to treat AV block, a condition marked by impaired neural signals between atrial and ventricular chambers in the heart. AV block can lead to irregular beat, and in some cases, increased risk

Boston Scientific has been granted FDA 510(k) clearance for their LUX-Dx insertable cardiac monitor system. This long-term diagnostic device is used to detect arrhythmias from conditions such as atrial fibrillation, syncope, and cryptogenic stroke. The LUX-Dx’s multi-stage algorithm first detects potential arrhythmias, then verifies them. When an arrhythmia is verified, clinicians are immediately alerted, so

According to the latest market analysis by iData Research, the U.S. atherectomy market is expected to remain as one of the biggest contributors to the growth of the peripheral vascular market. While often performed in conjunction with other procedures, such as angioplasties, atherectomy procedures have been experiencing double-digit growth rates for the past two years

According to the latest market analysis by iData Research, there are over 12,000 intravascular lithotripsy procedures performed in the United States every year. This number is expected to experience incredible growth and double in number by 2026. This growth can be attributed to two main factors: the creation of procedure codes by CMS, and successful

Abiomed has been granted FDA emergency use authorization for its Impella RP – a temporary heart pump to support circulatory system functioning in patients with right side ventricular failure. The FDA has granted EUA for this device to treat COVID-19 patients, as some of them have suffered from right heart failure due to the virus,